OXFENDAZOLE DEVELOPMENT GROUP

BLUE BELL, PA EIN 81-1547477 Medical ResearchH80 501C3 CHARITY

$9K

Revenue

Filings

$1.6M

Total Grants

Grant Records

Latest Financial Summary

Fiscal Year	Revenue	Expenses	Net Assets	Contributions
FY 2025	$9K	$227K	$100K	$935

Full Financial History

See all 4 years of revenue, expenses, net assets, and more.

Key Officers

R John Horton

President Board Member

Ellen Codd

Treasurer Board Member

Robert H Gilman

Board Member

Executive Compensation

View salary, bonus, and total compensation for all officers across all years.

Top Grant Recipients (Teaser)

Oxfendazole Development Group $1.6M

1 total grants · $1.6M total giving

Complete Grants Database

Search and filter all 1 grants with recipient EINs, purposes, and year-by-year breakdowns.

Filing History

Similar Organizations Medical Research · PA